Tuberculosis after renal transplantation.
Sharma
A K
AK
Monilek Hospital and Research Centre, Jaipur, India.
Tolani
S L
SL
Rathi
G L
GL
Gupta
H P
HP
Gupta
R
R
D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D007194:India; D007538:Isoniazid / Q000627:therapeutic use; D016030:Kidney Transplantation; D019520:Living Donors; D008297:Male; D011183:Postoperative Complications / Q000453:epidemiology / Q000382:microbiology; D011718:Pyrazinamide / Q000627:therapeutic use; D011736:Pyridoxine / Q000627:therapeutic use; D012189:Retrospective Studies; D012293:Rifampin / Q000627:therapeutic use; D013997:Time Factors; D014376:Tuberculosis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology* / Q000401:mortality; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000453:epidemiology
D000995:Antitubercular Agents; D011718:Pyrazinamide; D004977:Ethambutol; D011736:Pyridoxine; D007538:Isoniazid; D012293:Rifampin